Post by
TheMadMonk on Oct 22, 2021 5:58pm
Otena
Where did the one-billion-dollar valuation for Otena come from? Is this something the company said that they are looking for, was it what an analyst said it is worth, or is it just what people here feel like they would like to see for it?
Comment by
fox7mf on Oct 22, 2021 6:10pm
Just opinions. The pivot from chronic to acute represents a smaller market for Otena. Dan says the market they are now pursuing represents $13b annually & they're confident, if successful, Otena could capture 20% of said market. So, I believe Otena would go for closer to $2.5b.
Comment by
MrMugsy on Oct 23, 2021 4:30pm
Fox7 ... seems the $13B is absent the label expansion strategy for migraine, dental and menstral pain. Migraine alone could be a $2B industry. Therefore, numbers could be different from the $13B ... but weren't provided. Tough to say.
Comment by
WalkOverTheStrt on Oct 24, 2021 6:23pm
Is patent length on Otenal for acute same as chronic (ending 2032)? Slide deck changed.
Comment by
MrMugsy on Oct 24, 2021 6:57pm
From the latest news release ... - New patent application aimed at extending otenaproxesul’s IP protection into the 2040s https://www.businesswire.com/news/home/20211014005408/en/Antibe-Therapeutics-Provides-Update-on-Otenaproxesul-and-Expanded-Drug-Pipeline